Merck & Co., Inc. Moves Forward With Vioxx Successor

Published: Aug 23, 2006

CHICAGO (Reuters) - Drugmaker Merck & Co. on Wednesday gave preliminary results of a study of its investigational painkiller Arcoxia, the planned successor to Vioxx, which was pulled off the market in 2004 after being linked to stroke and heart attack.

>>> Discuss This Story

Back to news